• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

津巴布韦宫颈癌女性中顺铂诱导的毒性的流行情况及其预测因素。

Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer.

机构信息

University of Zimbabwe, Faculty of Medicine & Health Sciences, Harare, Zimbabwe.

Department of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Anzio Rd, Cape Town, 7700, South Africa.

出版信息

Future Oncol. 2024;20(26):1909-1924. doi: 10.1080/14796694.2024.2375959. Epub 2024 Jul 26.

DOI:10.1080/14796694.2024.2375959
PMID:39056302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11498005/
Abstract

To describe treatment-induced toxicities (TITs) and associated factors in Zimbabwean cancer patients receiving cisplatin. In total, 252 Zimbabwean women with cervical cancer, receiving cisplatin were followed up over 12 months for TITs and disease status. Peripheral neuropathy (70%) and ototoxicity (53%) were most prevalent. Advanced disease (OR = 1.3; 95% CI = 1.1-1.5; p = 0.02), pain comedications (OR = 1.3; 95% CI = 1.1-1.5; p = 0.03), alcohol (OR = 2.8; 95% CI = 1.1-7.5; p = 0.04) and comorbidities (OR = 1.2; 95% CI = 1.1-1.4; p = 0.04) increased peripheral neuropathy and ototoxicity risk. Older age increased risk of disease progression (OR = 1.9; 95% CI = 1.4-3.0; p = 0.033). High peripheral neuropathy and ototoxicity prevalence were observed, which are not routinely monitored in Zimbabwe. There is a need for capacity building to incorporate comprehensive TIT testing and optimize cancer care in Zimbabwe.

摘要

描述津巴布韦接受顺铂治疗的癌症患者的治疗相关毒性(TITs)及其相关因素。总共对 252 名接受顺铂治疗的津巴布韦宫颈癌女性患者进行了为期 12 个月的 TITs 和疾病状况随访。周围神经病变(70%)和耳毒性(53%)最为常见。晚期疾病(OR=1.3;95%CI=1.1-1.5;p=0.02)、疼痛合并用药(OR=1.3;95%CI=1.1-1.5;p=0.03)、饮酒(OR=2.8;95%CI=1.1-7.5;p=0.04)和合并症(OR=1.2;95%CI=1.1-1.4;p=0.04)增加了周围神经病变和耳毒性的风险。年龄越大,疾病进展的风险越高(OR=1.9;95%CI=1.4-3.0;p=0.033)。观察到高周围神经病变和耳毒性发生率,但津巴布韦并未常规监测这些毒性。因此,需要进行能力建设,以纳入全面的 TIT 检测并优化津巴布韦的癌症护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180e/11498005/b20818059e74/IFON_A_2375959_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180e/11498005/b25874e0412b/IFON_A_2375959_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180e/11498005/b20818059e74/IFON_A_2375959_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180e/11498005/b25874e0412b/IFON_A_2375959_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/180e/11498005/b20818059e74/IFON_A_2375959_F0002_C.jpg

相似文献

1
Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer.津巴布韦宫颈癌女性中顺铂诱导的毒性的流行情况及其预测因素。
Future Oncol. 2024;20(26):1909-1924. doi: 10.1080/14796694.2024.2375959. Epub 2024 Jul 26.
2
Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.顺铂相关性耳毒性在宫颈癌患者中的前瞻性队列研究:南非研究。
PLoS One. 2023 Apr 4;18(4):e0283639. doi: 10.1371/journal.pone.0283639. eCollection 2023.
3
Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.南非宫颈癌女性的基线听力学分析:评估顺铂相关性耳毒性的重要指标。
BMC Womens Health. 2021 Apr 20;21(1):164. doi: 10.1186/s12905-021-01313-5.
4
Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.在南非开展前瞻性队列研究,以调查癌症患者中顺铂相关性耳毒性的可行性和初步结果。
BMC Cancer. 2021 Jul 16;21(1):822. doi: 10.1186/s12885-021-08567-0.
5
Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.研究方案:接受癌症化疗患者中顺铂相关耳毒性及听力监测项目的可行性
BMC Womens Health. 2017 Dec 11;17(1):129. doi: 10.1186/s12905-017-0486-8.
6
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study.儿童、青少年和青年人群中顺铂所致听力损失的流行情况和危险因素:一项多机构北美队列研究。
Lancet Child Adolesc Health. 2021 Apr;5(4):274-283. doi: 10.1016/S2352-4642(21)00020-1. Epub 2021 Feb 12.
7
Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study.HPV 阳性口咽鳞癌中顺铂放化疗诱导耳毒性的临床预测因素:一项病例对照研究。
J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241248671. doi: 10.1177/19160216241248671.
8
Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.基于顺铂的化疗后的综合听力学分析。
JAMA Oncol. 2024 Jul 1;10(7):912-922. doi: 10.1001/jamaoncol.2024.1233.
9
Platinum-induced hearing loss after treatment for childhood cancer.儿童癌症治疗后铂诱导的听力损失。
Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2.
10
Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.DART试验中非洲HIV感染成人外周神经病变的患病率、发病率及预测因素
AIDS. 2014 Nov 13;28(17):2579-88. doi: 10.1097/QAD.0000000000000447.

引用本文的文献

1
Psychometric properties and longitudinal measurement invariance of the treatment-induced neuropathy assessment scale in the Chinese cancer chemotherapy population.中国癌症化疗人群中治疗引起的神经病变评估量表的心理测量学特性及纵向测量不变性
Sci Rep. 2025 Apr 8;15(1):11960. doi: 10.1038/s41598-025-96978-5.

本文引用的文献

1
Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.结直肠癌临床病理和分子肿瘤特征的种族差异:系统评价。
Cancer Causes Control. 2024 Feb;35(2):223-239. doi: 10.1007/s10552-023-01783-y. Epub 2023 Sep 9.
2
Clinical and demographic characteristics of cervical cancer patients presenting at Parirenyatwa Hospital, Zimbabwe.津巴布韦帕里伦亚图瓦医院宫颈癌患者的临床和人口统计学特征。
Afr J Reprod Health. 2021 Dec;25(6):99-109. doi: 10.29063/ajrh2021/v25i6.11.
3
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials.
结直肠癌治疗反应的种族多样性:基于放射组学的富集试验的概念验证。
Eur Radiol. 2023 Dec;33(12):9254-9261. doi: 10.1007/s00330-023-09862-z. Epub 2023 Jun 27.
4
Chemotherapeutic drugs induced female reproductive toxicity and treatment strategies.化疗药物诱导的女性生殖毒性及治疗策略。
J Biochem Mol Toxicol. 2023 Jul;37(7):e23371. doi: 10.1002/jbt.23371. Epub 2023 Apr 26.
5
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.美国新辅助化疗乳腺癌患者的治疗反应、种族和民族差异与生存
JAMA Netw Open. 2023 Mar 1;6(3):e235834. doi: 10.1001/jamanetworkopen.2023.5834.
6
A cervical cancer biorepository for pharmacogenomics research in Zimbabwe.津巴布韦宫颈癌生物样本库用于药物基因组学研究。
BMC Cancer. 2022 Dec 16;22(1):1320. doi: 10.1186/s12885-022-10413-w.
7
Assessment of cisplatin-induced nephrotoxicity and its associated factors among cervical cancer patients in the leading tertiary hospital in Kenya.评估肯尼亚一流三级医院宫颈癌患者顺铂诱导的肾毒性及其相关因素。
J Oncol Pharm Pract. 2022 Oct;28(7):1603-1608. doi: 10.1177/10781552221119417. Epub 2022 Aug 5.
8
Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy.顺铂联合天然产物在癌症化疗中的药理作用。
Int J Mol Sci. 2022 Jan 28;23(3):1532. doi: 10.3390/ijms23031532.
9
Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer.乳腺癌新辅助化疗后病理完全缓解的种族/民族差异及趋势
Cancers (Basel). 2022 Jan 21;14(3):534. doi: 10.3390/cancers14030534.
10
Chemotherapy-Induced Hepatotoxicity in HIV Patients.HIV 患者的化疗药物性肝损伤。
Cells. 2021 Oct 25;10(11):2871. doi: 10.3390/cells10112871.